ATLYPHE
Live / Registered — Registered (as of 16 Dec 2025)
What this means for you
Registered since 16 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79397822
- Registration number
- 8063937
- Mark type
- Stylized text
- Filed
- 14 Mar 2024
- Published for opposition
- 28 Oct 2025
- Registered
- 16 Dec 2025
- Attorney of record
- Paul Cosmovici
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of blood disorders, cardiovascular disorders, metabolic and endocrine disorders, immune system related diseases and disorders, oncological disorders, neurological disorders, infectious diseases, pain, inflammation; medical preparations for the treatment of blood disorders, cardiovascular disorders, metabolic and endocrine disorders, immune system related diseases and disorders, oncological disorders, neurological disorders, infectious diseases, pain, inflammation ; veterinary preparations for blood disorders; sanitary preparations for medical purposes; dietetic foods adapted for medical use; dietetic foods adapted for veterinary use; dietetic substances, namely, dietetic foods adapted for veterinary use; food for babies; dietary supplements for human beings and animals; plasters for medical purposes; materials for dressings, namely, gauze for dressings; materials for dental fillings and for making dental impressions; disinfectants; preparations for destroying vermin; fungicides, herbicides
- Class 042 — Scientific and technological services: Scientific services, namely, scientific research, analysis, testing, in the field of stems cells, immunotherapy, gene therapy; technological services, namely, medical research; scientific research; technological research in the field of medical diagnosis and healthcare; scientific and technological services, namely, research and design in the field of medical technology, devices and equipment; industrial analysis, namely, analysis and evaluation of medical and genetic data; industrial research in the field of immunotherapy, gene therapy and stems cells; industrial design services; quality control for others; quality authentication services, namely, authenticating organic and inorganic matters; design and development of computer hardware and software
Owner
- ATLyphe AG, CH
- ATLyphe AG, CH
- ATLyphe AG, CH
Prosecution history
- 16 Mar 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 16 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 05 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 19 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 19 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 28 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Oct 2025 — PUBLISHED FOR OPPOSITION
- 22 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE